Literature DB >> 29337533

Localized Fe(II)-Induced Cytotoxic Reactive Oxygen Species Generating Nanosystem for Enhanced Anticancer Therapy.

Yuxue Ding1, Jiaxun Wan1, Zihao Zhang1, Fang Wang1, Jia Guo1, Changchun Wang1.   

Abstract

The anticancer therapy on the basis of reactive oxygen species (ROS)-mediated cellular apoptosis has achieved great progress. However, this kind of theraputic strategy still faces some challenges such as light, photosensitizer and oxygen (O2) dependence. In this article, a ROS-mediated anticancer therapy independent of light, photosensitizer and oxygen was established based on a Fe2+-induced ROS-generating nanosystem. First, artemisinin (ART) was loaded in porous magnetic supraparticles (MSP) by a nanodeposition method. Then, the poly(aspartic acid)-based polymer, which consisted of dopamine, indocyanine green, and polyethylene glycol side chain, was coated onto the surface of ART-loaded MSP. When the nanoparticles entered into cancer cells, a reaction of Fe2+-mediated cleavage of the endoperoxide bridge contained in ART occurred and subsequent a large amount of ROS was generated. Moreover, a NIR light was used to effectively increase the local temperature of tumor in virtue of the superior photothermal effects of MSP, which enabled us to accelerate the ROS generation and achieved an enhanced ROS yield. The newly developed nanodrug system displayed a high level of intracellular ROS generation, leading to the desired killing efficacy against malignant cells and solid tumor. This smart nanosystem holds great potential to overcome the existing barrier in PDT and opens a promising avenue for anticancer therapy.

Entities:  

Keywords:  Fe2+-induced ROS generation; anticancer therapy; artemisinin; magnetic nanoparticles; reactive oxygen species

Mesh:

Substances:

Year:  2018        PMID: 29337533     DOI: 10.1021/acsami.7b16999

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  9 in total

1.  Poly(norepinephrine)-coated FeOOH nanoparticles as carriers of artemisinin for cancer photothermal-chemical combination therapy.

Authors:  Zi He; Huiling Su; Yuqing Shen; Wei Shi; Xin Liu; Yang Liu; Fuhui Zhang; Yansheng Zhang; Yanan Sun; Dongtao Ge
Journal:  RSC Adv       Date:  2019-03-29       Impact factor: 4.036

2.  Soft and Condensed Nanoparticles and Nanoformulations for Cancer Drug Delivery and Repurpose.

Authors:  Wen Yang; Hanitrarimalala Veroniaina; Xiaole Qi; Pengyu Chen; Feng Li; Pu Chun Ke
Journal:  Adv Ther (Weinh)       Date:  2019-10-16

Review 3.  Smart Responsive Nanoformulation for Targeted Delivery of Active Compounds From Traditional Chinese Medicine.

Authors:  Xuejun Jiang; Mei Lin; Jianwen Huang; Mulan Mo; Houhe Liu; Yuan Jiang; Xiaowen Cai; Wingnang Leung; Chuanshan Xu
Journal:  Front Chem       Date:  2020-12-10       Impact factor: 5.221

4.  Multiple stimuli-responsive nanosystem for potent, ROS-amplifying, chemo-sonodynamic antitumor therapy.

Authors:  JunJie Tang; Xiaoge Zhang; Lili Cheng; Yadong Liu; You Chen; Zhaozhong Jiang; Jie Liu
Journal:  Bioact Mater       Date:  2021-12-20

5.  H2O2-independent chemodynamic therapy initiated from magnetic iron carbide nanoparticle-assisted artemisinin synergy.

Authors:  Fan Zhao; Jing Yu; Weiliang Gao; Xue Yang; Liying Liang; Xiaolian Sun; Dan Su; Yao Ying; Wangchang Li; Juan Li; Jingwu Zheng; Liang Qiao; Wei Cai; Shenglei Che; Xiaozhou Mou
Journal:  RSC Adv       Date:  2021-11-22       Impact factor: 4.036

Review 6.  Antitumor Research on Artemisinin and Its Bioactive Derivatives.

Authors:  Yunqin Zhang; Guowei Xu; Shuqun Zhang; Dong Wang; P Saravana Prabha; Zhili Zuo
Journal:  Nat Prod Bioprospect       Date:  2018-04-09

7.  Synthesis of ginsenoside Re-based carbon dots applied for bioimaging and effective inhibition of cancer cells.

Authors:  Hua Yao; Jing Li; Yubin Song; Hong Zhao; Zhenhong Wei; Xiuying Li; Yongri Jin; Bai Yang; Jinlan Jiang
Journal:  Int J Nanomedicine       Date:  2018-10-09

8.  Dihydroartemisinin-Loaded Magnetic Nanoparticles for Enhanced Chemodynamic Therapy.

Authors:  Shengdi Guo; Xianxian Yao; Qin Jiang; Kuang Wang; Yuanying Zhang; Haibao Peng; Jing Tang; Wuli Yang
Journal:  Front Pharmacol       Date:  2020-03-10       Impact factor: 5.810

9.  Biological Evaluation in Resistant Cancer Cells and Study of Mechanism of Action of Arylvinyl-1,2,4-Trioxanes.

Authors:  Jerome P L Ng; Mohit K Tiwari; Ali Adnan Nasim; Rui Long Zhang; Yuanqing Qu; Richa Sharma; Betty Yuen Kwan Law; Dharmendra K Yadav; Sandeep Chaudhary; Paolo Coghi; Vincent Kam Wai Wong
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.